Description: GL Pharm Tech Corp. provides drug formulations and delivery technologies for generic and enhanced version of marketed drugs to pharmaceutical companies in Korea. The company offers incrementally modified drugs for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases, as well as for urology, pain, anti-infection, transplantation, and other areas. In addition, the company offers G-SOREN Tab, an oral herbal product for the prevention and treatment of gastritis; and KABALIN CR Tab for neuropathic pain associated with diabetic peripheral neuropathy and management of post herpetic neuralgia. GL Pharm Tech Corp. was founded in 2002 and is based in Seongnam, South Korea.
Home Page: www.glpt.co.kr
#714 Jungang Induspia V, 137
Seongnam,
South Korea
Phone:
82 3 1739 5220
Officers
| Name | Title |
|---|---|
| Mr. Hun-Sik Wang | Chief Exec. Officer |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.2313 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 20 |